Ivosidenib in the treatment of patients with cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy

Bull Cancer. 2023 Sep 11:S0007-4551(23)00274-6. doi: 10.1016/j.bulcan.2023.05.003. Online ahead of print.NO ABSTRACTPMID:37704495 | DOI:10.1016/j.bulcan.2023.05.003

Source: Bulletin du Cancer - September 13, 2023 Category: Cancer & Oncology Authors: Tarik Rabehi Stanislas Quesada Source Type: research